1. Home
  2. LMB vs NBTX Comparison

LMB vs NBTX Comparison

Compare LMB & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Limbach Holdings Inc.

LMB

Limbach Holdings Inc.

HOLD

Current Price

$72.72

Market Cap

1.2B

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$51.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LMB
NBTX
Founded
1901
2003
Country
United States
France
Employees
1400
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
LMB
NBTX
Price
$72.72
$51.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$116.67
$36.00
AVG Volume (30 Days)
310.6K
68.3K
Earning Date
05-05-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
25.68
N/A
EPS
0.36
N/A
Revenue
$646,804,000.00
N/A
Revenue This Year
$15.96
$58.17
Revenue Next Year
$5.90
N/A
P/E Ratio
$207.75
N/A
Revenue Growth
24.68
N/A
52 Week Low
$65.08
$3.64
52 Week High
$154.04
$57.14

Technical Indicators

Market Signals
Indicator
LMB
NBTX
Relative Strength Index (RSI) 40.25 65.31
Support Level $71.40 $19.22
Resistance Level $85.38 N/A
Average True Range (ATR) 6.95 3.29
MACD -2.73 1.71
Stochastic Oscillator 3.91 77.12

Price Performance

Historical Comparison
LMB
NBTX

About LMB Limbach Holdings Inc.

Limbach Holdings Inc is a building systems solutions firm that designs, delivers, and maintains mechanical (heating, ventilation, and air conditioning), electrical, plumbing, and controls (MEPC) systems. The Company partners with owners and operators of facilities across healthcare, industrial and manufacturing, data centers, life sciences, higher education, and cultural and entertainment markets. It operates through two segments: Owner Direct Relationships (ODR), which generates maximum revenue and includes owner direct projects, maintenance, and service on MEPC systems; and General Contractor Relationships (GCR), which manages new construction or renovation projects involving MEPC systems awarded by general contractors or construction managers.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: